Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
US Radiology Specialists, recently rebranded as Lumexa Imaging (NASDAQ: LMRI), is a leading national provider of outpatient diagnostic imaging services in the United States. Established in 2018 through a joint venture between Charlotte Radiology and the private equity firm Welsh, Carson, Anderson & Stowe, the company has rapidly scaled to operate over 185 imaging centers across 14 states. Its comprehensive service offerings include advanced modalities such as MRI, CT, PET, and mammography, supported by a network of more than 1,000 subspecialized radiologists. The company utilizes a unique physician-led governance model and integrates AI-driven technologies to enhance clinical accuracy and operational efficiency. Following its initial public offering in December 2025, Lumexa continues to drive growth through de novo center development and strategic partnerships with major health systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on US Radiology.